nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—OPRD1—Amitriptyline—migraine	0.216	0.272	CbGbCtD
Hydrocodone—OPRK1—Amitriptyline—migraine	0.18	0.227	CbGbCtD
Hydrocodone—OPRM1—Amitriptyline—migraine	0.159	0.2	CbGbCtD
Hydrocodone—CYP2D6—Timolol—migraine	0.0428	0.0539	CbGbCtD
Hydrocodone—CYP2D6—Propranolol—migraine	0.0381	0.048	CbGbCtD
Hydrocodone—CYP2D6—Amitriptyline—migraine	0.033	0.0416	CbGbCtD
Hydrocodone—CYP2D6—Verapamil—migraine	0.0262	0.033	CbGbCtD
Hydrocodone—CYP3A4—Propranolol—migraine	0.0242	0.0306	CbGbCtD
Hydrocodone—CYP3A4—Amitriptyline—migraine	0.021	0.0264	CbGbCtD
Hydrocodone—CYP3A4—Valproic Acid—migraine	0.0191	0.0241	CbGbCtD
Hydrocodone—CYP3A4—Topiramate—migraine	0.0172	0.0217	CbGbCtD
Hydrocodone—CYP3A4—Verapamil—migraine	0.0166	0.021	CbGbCtD
Hydrocodone—Naloxone—ESR1—migraine	0.00085	0.625	CrCbGaD
Hydrocodone—Lethargy—Gabapentin—migraine	0.000793	0.0048	CcSEcCtD
Hydrocodone—Mood swings—Timolol—migraine	0.00079	0.00478	CcSEcCtD
Hydrocodone—Insomnia—Amitriptyline—migraine	0.000784	0.00475	CcSEcCtD
Hydrocodone—Paraesthesia—Amitriptyline—migraine	0.000779	0.00471	CcSEcCtD
Hydrocodone—Osteoarthritis—Gabapentin—migraine	0.000777	0.0047	CcSEcCtD
Hydrocodone—Pain in extremity—Gabapentin—migraine	0.000777	0.0047	CcSEcCtD
Hydrocodone—Abdominal discomfort—Valproic Acid—migraine	0.000776	0.0047	CcSEcCtD
Hydrocodone—Somnolence—Amitriptyline—migraine	0.000771	0.00467	CcSEcCtD
Hydrocodone—Muscle spasms—Verapamil—migraine	0.000765	0.00463	CcSEcCtD
Hydrocodone—Migraine—Gabapentin—migraine	0.000765	0.00463	CcSEcCtD
Hydrocodone—Affect lability—Gabapentin—migraine	0.000765	0.00463	CcSEcCtD
Hydrocodone—Cough—Propranolol—migraine	0.000755	0.00457	CcSEcCtD
Hydrocodone—Convulsion—Propranolol—migraine	0.00075	0.00454	CcSEcCtD
Hydrocodone—Fatigue—Amitriptyline—migraine	0.000748	0.00452	CcSEcCtD
Hydrocodone—Tremor—Verapamil—migraine	0.000746	0.00451	CcSEcCtD
Hydrocodone—Constipation—Amitriptyline—migraine	0.000742	0.00449	CcSEcCtD
Hydrocodone—Urinary retention—Gabapentin—migraine	0.000739	0.00447	CcSEcCtD
Hydrocodone—Mood swings—Gabapentin—migraine	0.000736	0.00445	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.000731	0.00443	CcSEcCtD
Hydrocodone—Deafness—Topiramate—migraine	0.00073	0.00442	CcSEcCtD
Hydrocodone—Dehydration—Gabapentin—migraine	0.000722	0.00437	CcSEcCtD
Hydrocodone—Drowsiness—Valproic Acid—migraine	0.000722	0.00437	CcSEcCtD
Hydrocodone—Urinary tract infection—Valproic Acid—migraine	0.000702	0.00425	CcSEcCtD
Hydrocodone—Hot flush—Topiramate—migraine	0.000699	0.00423	CcSEcCtD
Hydrocodone—Menopausal symptoms—Topiramate—migraine	0.000693	0.00419	CcSEcCtD
Hydrocodone—Nervous system disorder—Propranolol—migraine	0.000692	0.00419	CcSEcCtD
Hydrocodone—Convulsion—Verapamil—migraine	0.00069	0.00417	CcSEcCtD
Hydrocodone—Skin disorder—Propranolol—migraine	0.000686	0.00415	CcSEcCtD
Hydrocodone—Body temperature increased—Amitriptyline—migraine	0.000685	0.00415	CcSEcCtD
Hydrocodone—Myalgia—Verapamil—migraine	0.000678	0.0041	CcSEcCtD
Hydrocodone—Arthralgia—Verapamil—migraine	0.000678	0.0041	CcSEcCtD
Hydrocodone—Agranulocytosis—Valproic Acid—migraine	0.000674	0.00408	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Timolol—migraine	0.00067	0.00406	CcSEcCtD
Hydrocodone—Lethargy—Topiramate—migraine	0.000667	0.00404	CcSEcCtD
Hydrocodone—Dry mouth—Verapamil—migraine	0.000663	0.00401	CcSEcCtD
Hydrocodone—Pain in extremity—Topiramate—migraine	0.000653	0.00396	CcSEcCtD
Hydrocodone—Osteoarthritis—Topiramate—migraine	0.000653	0.00396	CcSEcCtD
Hydrocodone—Migraine—Topiramate—migraine	0.000643	0.00389	CcSEcCtD
Hydrocodone—Affect lability—Topiramate—migraine	0.000643	0.00389	CcSEcCtD
Hydrocodone—Insomnia—Propranolol—migraine	0.000639	0.00386	CcSEcCtD
Hydrocodone—Oedema peripheral—Valproic Acid—migraine	0.000639	0.00386	CcSEcCtD
Hydrocodone—Connective tissue disorder—Valproic Acid—migraine	0.000637	0.00386	CcSEcCtD
Hydrocodone—Paraesthesia—Propranolol—migraine	0.000634	0.00384	CcSEcCtD
Hydrocodone—Dyspnoea—Propranolol—migraine	0.000629	0.00381	CcSEcCtD
Hydrocodone—Hyperhidrosis—Verapamil—migraine	0.000628	0.0038	CcSEcCtD
Hydrocodone—Somnolence—Propranolol—migraine	0.000628	0.0038	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Gabapentin—migraine	0.000624	0.00378	CcSEcCtD
Hydrocodone—Asthenia—Amitriptyline—migraine	0.000622	0.00377	CcSEcCtD
Hydrocodone—Urinary retention—Topiramate—migraine	0.000621	0.00376	CcSEcCtD
Hydrocodone—Mood swings—Topiramate—migraine	0.000619	0.00375	CcSEcCtD
Hydrocodone—Pruritus—Amitriptyline—migraine	0.000614	0.00371	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Propranolol—migraine	0.00061	0.00369	CcSEcCtD
Hydrocodone—Fatigue—Propranolol—migraine	0.000609	0.00368	CcSEcCtD
Hydrocodone—Dehydration—Topiramate—migraine	0.000608	0.00368	CcSEcCtD
Hydrocodone—Hypotension—Verapamil—migraine	0.000607	0.00367	CcSEcCtD
Hydrocodone—Constipation—Propranolol—migraine	0.000604	0.00365	CcSEcCtD
Hydrocodone—Agranulocytosis—Timolol—migraine	0.0006	0.00363	CcSEcCtD
Hydrocodone—Drowsiness—Gabapentin—migraine	0.000599	0.00362	CcSEcCtD
Hydrocodone—Hypokalaemia—Topiramate—migraine	0.000595	0.0036	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Verapamil—migraine	0.000592	0.00358	CcSEcCtD
Hydrocodone—Angiopathy—Valproic Acid—migraine	0.000588	0.00356	CcSEcCtD
Hydrocodone—Insomnia—Verapamil—migraine	0.000587	0.00356	CcSEcCtD
Hydrocodone—Mediastinal disorder—Valproic Acid—migraine	0.000584	0.00354	CcSEcCtD
Hydrocodone—Paraesthesia—Verapamil—migraine	0.000583	0.00353	CcSEcCtD
Hydrocodone—Urinary tract infection—Gabapentin—migraine	0.000582	0.00352	CcSEcCtD
Hydrocodone—Dyspnoea—Verapamil—migraine	0.000579	0.0035	CcSEcCtD
Hydrocodone—Somnolence—Verapamil—migraine	0.000577	0.00349	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Propranolol—migraine	0.000577	0.00349	CcSEcCtD
Hydrocodone—Dizziness—Amitriptyline—migraine	0.000573	0.00347	CcSEcCtD
Hydrocodone—Oedema peripheral—Timolol—migraine	0.000568	0.00344	CcSEcCtD
Hydrocodone—Mental disorder—Valproic Acid—migraine	0.000568	0.00344	CcSEcCtD
Hydrocodone—Connective tissue disorder—Timolol—migraine	0.000567	0.00343	CcSEcCtD
Hydrocodone—Malnutrition—Valproic Acid—migraine	0.000564	0.00342	CcSEcCtD
Hydrocodone—Fatigue—Verapamil—migraine	0.00056	0.00339	CcSEcCtD
Hydrocodone—Body temperature increased—Propranolol—migraine	0.000558	0.00338	CcSEcCtD
Hydrocodone—Abdominal pain—Propranolol—migraine	0.000558	0.00338	CcSEcCtD
Hydrocodone—Constipation—Verapamil—migraine	0.000555	0.00336	CcSEcCtD
Hydrocodone—Vomiting—Amitriptyline—migraine	0.000551	0.00334	CcSEcCtD
Hydrocodone—Rash—Amitriptyline—migraine	0.000547	0.00331	CcSEcCtD
Hydrocodone—Dermatitis—Amitriptyline—migraine	0.000546	0.00331	CcSEcCtD
Hydrocodone—Back pain—Valproic Acid—migraine	0.000546	0.0033	CcSEcCtD
Hydrocodone—Headache—Amitriptyline—migraine	0.000543	0.00329	CcSEcCtD
Hydrocodone—Muscle spasms—Valproic Acid—migraine	0.000542	0.00328	CcSEcCtD
Hydrocodone—Abdominal discomfort—Topiramate—migraine	0.000541	0.00328	CcSEcCtD
Hydrocodone—Oedema peripheral—Gabapentin—migraine	0.000529	0.0032	CcSEcCtD
Hydrocodone—Tremor—Valproic Acid—migraine	0.000529	0.0032	CcSEcCtD
Hydrocodone—Connective tissue disorder—Gabapentin—migraine	0.000528	0.0032	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Topiramate—migraine	0.000525	0.00318	CcSEcCtD
Hydrocodone—Angiopathy—Timolol—migraine	0.000524	0.00317	CcSEcCtD
Hydrocodone—Hypersensitivity—Propranolol—migraine	0.00052	0.00315	CcSEcCtD
Hydrocodone—Mediastinal disorder—Timolol—migraine	0.00052	0.00315	CcSEcCtD
Hydrocodone—Nausea—Amitriptyline—migraine	0.000515	0.00312	CcSEcCtD
Hydrocodone—Dextromethorphan—SLC6A4—migraine	0.00051	0.375	CrCbGaD
Hydrocodone—Asthenia—Propranolol—migraine	0.000507	0.00307	CcSEcCtD
Hydrocodone—Mental disorder—Timolol—migraine	0.000506	0.00306	CcSEcCtD
Hydrocodone—Malnutrition—Timolol—migraine	0.000502	0.00304	CcSEcCtD
Hydrocodone—Cough—Valproic Acid—migraine	0.000492	0.00298	CcSEcCtD
Hydrocodone—Urinary tract infection—Topiramate—migraine	0.000489	0.00296	CcSEcCtD
Hydrocodone—Mediastinal disorder—Gabapentin—migraine	0.000484	0.00293	CcSEcCtD
Hydrocodone—Myalgia—Valproic Acid—migraine	0.00048	0.00291	CcSEcCtD
Hydrocodone—Arthralgia—Valproic Acid—migraine	0.00048	0.00291	CcSEcCtD
Hydrocodone—Anxiety—Valproic Acid—migraine	0.000479	0.0029	CcSEcCtD
Hydrocodone—Hypersensitivity—Verapamil—migraine	0.000479	0.0029	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000477	0.00289	CcSEcCtD
Hydrocodone—Mental disorder—Gabapentin—migraine	0.000471	0.00285	CcSEcCtD
Hydrocodone—Agranulocytosis—Topiramate—migraine	0.00047	0.00284	CcSEcCtD
Hydrocodone—Dry mouth—Valproic Acid—migraine	0.00047	0.00284	CcSEcCtD
Hydrocodone—Malnutrition—Gabapentin—migraine	0.000468	0.00283	CcSEcCtD
Hydrocodone—Dizziness—Propranolol—migraine	0.000467	0.00283	CcSEcCtD
Hydrocodone—Asthenia—Verapamil—migraine	0.000466	0.00282	CcSEcCtD
Hydrocodone—Pruritus—Verapamil—migraine	0.00046	0.00278	CcSEcCtD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000453	0.0114	CbGpPWpGaD
Hydrocodone—Back pain—Gabapentin—migraine	0.000452	0.00274	CcSEcCtD
Hydrocodone—Nervous system disorder—Valproic Acid—migraine	0.000452	0.00273	CcSEcCtD
Hydrocodone—Thrombocytopenia—Valproic Acid—migraine	0.000451	0.00273	CcSEcCtD
Hydrocodone—Muscle spasms—Gabapentin—migraine	0.00045	0.00272	CcSEcCtD
Hydrocodone—Vomiting—Propranolol—migraine	0.000449	0.00272	CcSEcCtD
Hydrocodone—Skin disorder—Valproic Acid—migraine	0.000447	0.00271	CcSEcCtD
Hydrocodone—Oedema peripheral—Topiramate—migraine	0.000445	0.0027	CcSEcCtD
Hydrocodone—Hyperhidrosis—Valproic Acid—migraine	0.000445	0.00269	CcSEcCtD
Hydrocodone—Rash—Propranolol—migraine	0.000445	0.00269	CcSEcCtD
Hydrocodone—Dermatitis—Propranolol—migraine	0.000445	0.00269	CcSEcCtD
Hydrocodone—Connective tissue disorder—Topiramate—migraine	0.000444	0.00269	CcSEcCtD
Hydrocodone—Cough—Timolol—migraine	0.000438	0.00265	CcSEcCtD
Hydrocodone—Tremor—Gabapentin—migraine	0.000438	0.00265	CcSEcCtD
Hydrocodone—Hypotension—Valproic Acid—migraine	0.00043	0.0026	CcSEcCtD
Hydrocodone—Dizziness—Verapamil—migraine	0.000429	0.0026	CcSEcCtD
Hydrocodone—OPRK1—G alpha (i) signalling events—HTR1D—migraine	0.000428	0.0107	CbGpPWpGaD
Hydrocodone—Arthralgia—Timolol—migraine	0.000428	0.00259	CcSEcCtD
Hydrocodone—Myalgia—Timolol—migraine	0.000428	0.00259	CcSEcCtD
Hydrocodone—Anxiety—Timolol—migraine	0.000426	0.00258	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000425	0.00257	CcSEcCtD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000421	0.0106	CbGpPWpGaD
Hydrocodone—Musculoskeletal discomfort—Valproic Acid—migraine	0.00042	0.00254	CcSEcCtD
Hydrocodone—Nausea—Propranolol—migraine	0.000419	0.00254	CcSEcCtD
Hydrocodone—Dry mouth—Timolol—migraine	0.000418	0.00253	CcSEcCtD
Hydrocodone—Insomnia—Valproic Acid—migraine	0.000417	0.00252	CcSEcCtD
Hydrocodone—Paraesthesia—Valproic Acid—migraine	0.000414	0.0025	CcSEcCtD
Hydrocodone—Vomiting—Verapamil—migraine	0.000413	0.0025	CcSEcCtD
Hydrocodone—Dyspnoea—Valproic Acid—migraine	0.000411	0.00248	CcSEcCtD
Hydrocodone—Angiopathy—Topiramate—migraine	0.00041	0.00248	CcSEcCtD
Hydrocodone—Rash—Verapamil—migraine	0.00041	0.00248	CcSEcCtD
Hydrocodone—Somnolence—Valproic Acid—migraine	0.000409	0.00248	CcSEcCtD
Hydrocodone—Dermatitis—Verapamil—migraine	0.000409	0.00248	CcSEcCtD
Hydrocodone—Cough—Gabapentin—migraine	0.000408	0.00247	CcSEcCtD
Hydrocodone—Mediastinal disorder—Topiramate—migraine	0.000407	0.00247	CcSEcCtD
Hydrocodone—Headache—Verapamil—migraine	0.000407	0.00246	CcSEcCtD
Hydrocodone—OPRD1—GPCR ligand binding—CALCRL—migraine	0.000407	0.0102	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—RAMP1—migraine	0.000407	0.0102	CbGpPWpGaD
Hydrocodone—Convulsion—Gabapentin—migraine	0.000405	0.00245	CcSEcCtD
Hydrocodone—Nervous system disorder—Timolol—migraine	0.000402	0.00243	CcSEcCtD
Hydrocodone—Myalgia—Gabapentin—migraine	0.000398	0.00241	CcSEcCtD
Hydrocodone—Arthralgia—Gabapentin—migraine	0.000398	0.00241	CcSEcCtD
Hydrocodone—Skin disorder—Timolol—migraine	0.000398	0.00241	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Valproic Acid—migraine	0.000398	0.00241	CcSEcCtD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000397	0.00997	CbGpPWpGaD
Hydrocodone—Fatigue—Valproic Acid—migraine	0.000397	0.0024	CcSEcCtD
Hydrocodone—Anxiety—Gabapentin—migraine	0.000397	0.0024	CcSEcCtD
Hydrocodone—Hyperhidrosis—Timolol—migraine	0.000396	0.0024	CcSEcCtD
Hydrocodone—Mental disorder—Topiramate—migraine	0.000396	0.0024	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000395	0.00239	CcSEcCtD
Hydrocodone—Constipation—Valproic Acid—migraine	0.000394	0.00238	CcSEcCtD
Hydrocodone—Malnutrition—Topiramate—migraine	0.000394	0.00238	CcSEcCtD
Hydrocodone—Dry mouth—Gabapentin—migraine	0.000389	0.00236	CcSEcCtD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000388	0.00974	CbGpPWpGaD
Hydrocodone—Nausea—Verapamil—migraine	0.000386	0.00233	CcSEcCtD
Hydrocodone—Hypotension—Timolol—migraine	0.000383	0.00232	CcSEcCtD
Hydrocodone—Back pain—Topiramate—migraine	0.000381	0.0023	CcSEcCtD
Hydrocodone—Muscle spasms—Topiramate—migraine	0.000378	0.00229	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Valproic Acid—migraine	0.000377	0.00228	CcSEcCtD
Hydrocodone—Nervous system disorder—Gabapentin—migraine	0.000374	0.00227	CcSEcCtD
Hydrocodone—Thrombocytopenia—Gabapentin—migraine	0.000374	0.00226	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Timolol—migraine	0.000373	0.00226	CcSEcCtD
Hydrocodone—Skin disorder—Gabapentin—migraine	0.000371	0.00224	CcSEcCtD
Hydrocodone—Insomnia—Timolol—migraine	0.000371	0.00224	CcSEcCtD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000369	0.00927	CbGpPWpGaD
Hydrocodone—Hyperhidrosis—Gabapentin—migraine	0.000369	0.00223	CcSEcCtD
Hydrocodone—Tremor—Topiramate—migraine	0.000369	0.00223	CcSEcCtD
Hydrocodone—Paraesthesia—Timolol—migraine	0.000368	0.00223	CcSEcCtD
Hydrocodone—Dyspnoea—Timolol—migraine	0.000365	0.00221	CcSEcCtD
Hydrocodone—Somnolence—Timolol—migraine	0.000364	0.00221	CcSEcCtD
Hydrocodone—Body temperature increased—Valproic Acid—migraine	0.000364	0.0022	CcSEcCtD
Hydrocodone—Abdominal pain—Valproic Acid—migraine	0.000364	0.0022	CcSEcCtD
Hydrocodone—OPRM1—G alpha (i) signalling events—HTR1D—migraine	0.000362	0.00908	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000361	0.00906	CbGpPWpGaD
Hydrocodone—Hypotension—Gabapentin—migraine	0.000357	0.00216	CcSEcCtD
Hydrocodone—OPRK1—GPCR ligand binding—RAMP1—migraine	0.000357	0.00895	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CALCRL—migraine	0.000357	0.00895	CbGpPWpGaD
Hydrocodone—Gastrointestinal disorder—Timolol—migraine	0.000354	0.00214	CcSEcCtD
Hydrocodone—Fatigue—Timolol—migraine	0.000353	0.00214	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Gabapentin—migraine	0.000348	0.00211	CcSEcCtD
Hydrocodone—Insomnia—Gabapentin—migraine	0.000345	0.00209	CcSEcCtD
Hydrocodone—Cough—Topiramate—migraine	0.000343	0.00208	CcSEcCtD
Hydrocodone—Paraesthesia—Gabapentin—migraine	0.000343	0.00207	CcSEcCtD
Hydrocodone—Convulsion—Topiramate—migraine	0.000341	0.00206	CcSEcCtD
Hydrocodone—Dyspnoea—Gabapentin—migraine	0.00034	0.00206	CcSEcCtD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00034	0.00854	CbGpPWpGaD
Hydrocodone—Somnolence—Gabapentin—migraine	0.000339	0.00205	CcSEcCtD
Hydrocodone—Hypersensitivity—Valproic Acid—migraine	0.000339	0.00205	CcSEcCtD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000336	0.00843	CbGpPWpGaD
Hydrocodone—Gastrointestinal pain—Timolol—migraine	0.000335	0.00203	CcSEcCtD
Hydrocodone—Myalgia—Topiramate—migraine	0.000335	0.00203	CcSEcCtD
Hydrocodone—Arthralgia—Topiramate—migraine	0.000335	0.00203	CcSEcCtD
Hydrocodone—Anxiety—Topiramate—migraine	0.000334	0.00202	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000333	0.00201	CcSEcCtD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—NPS—migraine	0.000332	0.00834	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—TAC1—migraine	0.000332	0.00834	CbGpPWpGaD
Hydrocodone—Asthenia—Valproic Acid—migraine	0.00033	0.002	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Gabapentin—migraine	0.00033	0.00199	CcSEcCtD
Hydrocodone—Fatigue—Gabapentin—migraine	0.000329	0.00199	CcSEcCtD
Hydrocodone—Dry mouth—Topiramate—migraine	0.000328	0.00198	CcSEcCtD
Hydrocodone—Constipation—Gabapentin—migraine	0.000326	0.00198	CcSEcCtD
Hydrocodone—Pruritus—Valproic Acid—migraine	0.000326	0.00197	CcSEcCtD
Hydrocodone—Body temperature increased—Timolol—migraine	0.000324	0.00196	CcSEcCtD
Hydrocodone—Abdominal pain—Timolol—migraine	0.000324	0.00196	CcSEcCtD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—EDNRA—migraine	0.000317	0.00796	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000316	0.00794	CbGpPWpGaD
Hydrocodone—Nervous system disorder—Topiramate—migraine	0.000315	0.00191	CcSEcCtD
Hydrocodone—Thrombocytopenia—Topiramate—migraine	0.000314	0.0019	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Gabapentin—migraine	0.000312	0.00189	CcSEcCtD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000312	0.00784	CbGpPWpGaD
Hydrocodone—Skin disorder—Topiramate—migraine	0.000312	0.00189	CcSEcCtD
Hydrocodone—Hyperhidrosis—Topiramate—migraine	0.00031	0.00188	CcSEcCtD
Hydrocodone—Dizziness—Valproic Acid—migraine	0.000305	0.00184	CcSEcCtD
Hydrocodone—Hypersensitivity—Timolol—migraine	0.000302	0.00183	CcSEcCtD
Hydrocodone—Body temperature increased—Gabapentin—migraine	0.000302	0.00183	CcSEcCtD
Hydrocodone—Abdominal pain—Gabapentin—migraine	0.000302	0.00183	CcSEcCtD
Hydrocodone—OPRM1—GPCR ligand binding—RAMP1—migraine	0.000301	0.00757	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CALCRL—migraine	0.000301	0.00757	CbGpPWpGaD
Hydrocodone—Hypotension—Topiramate—migraine	0.0003	0.00182	CcSEcCtD
Hydrocodone—OPRD1—G alpha (i) signalling events—HTR1B—migraine	0.000296	0.00742	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—HTR1D—migraine	0.000296	0.00742	CbGpPWpGaD
Hydrocodone—Asthenia—Timolol—migraine	0.000294	0.00178	CcSEcCtD
Hydrocodone—Vomiting—Valproic Acid—migraine	0.000293	0.00177	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Topiramate—migraine	0.000293	0.00177	CcSEcCtD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—NPS—migraine	0.000291	0.00732	CbGpPWpGaD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—TAC1—migraine	0.000291	0.00732	CbGpPWpGaD
Hydrocodone—Insomnia—Topiramate—migraine	0.00029	0.00176	CcSEcCtD
Hydrocodone—Rash—Valproic Acid—migraine	0.00029	0.00176	CcSEcCtD
Hydrocodone—Dermatitis—Valproic Acid—migraine	0.00029	0.00176	CcSEcCtD
Hydrocodone—Pruritus—Timolol—migraine	0.00029	0.00176	CcSEcCtD
Hydrocodone—Headache—Valproic Acid—migraine	0.000288	0.00175	CcSEcCtD
Hydrocodone—Paraesthesia—Topiramate—migraine	0.000288	0.00175	CcSEcCtD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000288	0.00722	CbGpPWpGaD
Hydrocodone—Dyspnoea—Topiramate—migraine	0.000286	0.00173	CcSEcCtD
Hydrocodone—Somnolence—Topiramate—migraine	0.000286	0.00173	CcSEcCtD
Hydrocodone—OPRD1—G alpha (i) signalling events—HTR1A—migraine	0.000285	0.00715	CbGpPWpGaD
Hydrocodone—Hypersensitivity—Gabapentin—migraine	0.000281	0.0017	CcSEcCtD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—EDNRA—migraine	0.000278	0.00698	CbGpPWpGaD
Hydrocodone—Gastrointestinal disorder—Topiramate—migraine	0.000277	0.00168	CcSEcCtD
Hydrocodone—Fatigue—Topiramate—migraine	0.000277	0.00168	CcSEcCtD
Hydrocodone—OPRD1—GPCR ligand binding—HTR2B—migraine	0.000275	0.0069	CbGpPWpGaD
Hydrocodone—Constipation—Topiramate—migraine	0.000275	0.00166	CcSEcCtD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000274	0.00689	CbGpPWpGaD
Hydrocodone—Asthenia—Gabapentin—migraine	0.000274	0.00166	CcSEcCtD
Hydrocodone—Nausea—Valproic Acid—migraine	0.000274	0.00166	CcSEcCtD
Hydrocodone—Dizziness—Timolol—migraine	0.000271	0.00164	CcSEcCtD
Hydrocodone—Pruritus—Gabapentin—migraine	0.00027	0.00163	CcSEcCtD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000267	0.00671	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000264	0.00663	CbGpPWpGaD
Hydrocodone—Gastrointestinal pain—Topiramate—migraine	0.000263	0.00159	CcSEcCtD
Hydrocodone—Vomiting—Timolol—migraine	0.000261	0.00158	CcSEcCtD
Hydrocodone—OPRK1—G alpha (i) signalling events—HTR1B—migraine	0.000259	0.00651	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—HTR1D—migraine	0.000259	0.00651	CbGpPWpGaD
Hydrocodone—Rash—Timolol—migraine	0.000258	0.00156	CcSEcCtD
Hydrocodone—Dermatitis—Timolol—migraine	0.000258	0.00156	CcSEcCtD
Hydrocodone—Headache—Timolol—migraine	0.000257	0.00155	CcSEcCtD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000255	0.00641	CbGpPWpGaD
Hydrocodone—Abdominal pain—Topiramate—migraine	0.000254	0.00154	CcSEcCtD
Hydrocodone—Body temperature increased—Topiramate—migraine	0.000254	0.00154	CcSEcCtD
Hydrocodone—Dizziness—Gabapentin—migraine	0.000252	0.00153	CcSEcCtD
Hydrocodone—OPRK1—G alpha (i) signalling events—HTR1A—migraine	0.00025	0.00627	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000248	0.00623	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—TAC1—migraine	0.000246	0.00618	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—NPS—migraine	0.000246	0.00618	CbGpPWpGaD
Hydrocodone—Nausea—Timolol—migraine	0.000244	0.00147	CcSEcCtD
Hydrocodone—Vomiting—Gabapentin—migraine	0.000243	0.00147	CcSEcCtD
Hydrocodone—OPRK1—GPCR ligand binding—HTR2B—migraine	0.000241	0.00605	CbGpPWpGaD
Hydrocodone—Rash—Gabapentin—migraine	0.000241	0.00146	CcSEcCtD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000241	0.00604	CbGpPWpGaD
Hydrocodone—Dermatitis—Gabapentin—migraine	0.00024	0.00146	CcSEcCtD
Hydrocodone—Headache—Gabapentin—migraine	0.000239	0.00145	CcSEcCtD
Hydrocodone—Hypersensitivity—Topiramate—migraine	0.000237	0.00143	CcSEcCtD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000235	0.0059	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—EDNRA—migraine	0.000235	0.0059	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000232	0.00582	CbGpPWpGaD
Hydrocodone—Asthenia—Topiramate—migraine	0.00023	0.00139	CcSEcCtD
Hydrocodone—OPRD1—GPCR downstream signaling—CALCRL—migraine	0.00023	0.00577	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—RAMP1—migraine	0.00023	0.00577	CbGpPWpGaD
Hydrocodone—Pruritus—Topiramate—migraine	0.000227	0.00138	CcSEcCtD
Hydrocodone—Nausea—Gabapentin—migraine	0.000227	0.00137	CcSEcCtD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000226	0.00568	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000224	0.00562	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000223	0.00561	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000223	0.0056	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000223	0.0056	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—HTR1B—migraine	0.000219	0.0055	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—HTR1D—migraine	0.000219	0.0055	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000219	0.00549	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000218	0.00546	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—FOS—migraine	0.000215	0.00541	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000213	0.00534	CbGpPWpGaD
Hydrocodone—Dizziness—Topiramate—migraine	0.000212	0.00129	CcSEcCtD
Hydrocodone—OPRM1—G alpha (i) signalling events—HTR1A—migraine	0.000211	0.0053	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—RAMP1—migraine	0.000209	0.00524	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CALCRL—migraine	0.000209	0.00524	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000206	0.00518	CbGpPWpGaD
Hydrocodone—Vomiting—Topiramate—migraine	0.000204	0.00124	CcSEcCtD
Hydrocodone—OPRM1—GPCR ligand binding—HTR2B—migraine	0.000204	0.00511	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000203	0.00511	CbGpPWpGaD
Hydrocodone—Rash—Topiramate—migraine	0.000203	0.00123	CcSEcCtD
Hydrocodone—Dermatitis—Topiramate—migraine	0.000202	0.00122	CcSEcCtD
Hydrocodone—OPRK1—GPCR downstream signaling—RAMP1—migraine	0.000202	0.00506	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CALCRL—migraine	0.000202	0.00506	CbGpPWpGaD
Hydrocodone—Headache—Topiramate—migraine	0.000201	0.00122	CcSEcCtD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000198	0.00498	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000196	0.00492	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000196	0.00492	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000195	0.00491	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000195	0.00491	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000192	0.00481	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000191	0.00481	CbGpPWpGaD
Hydrocodone—Nausea—Topiramate—migraine	0.000191	0.00115	CcSEcCtD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000189	0.00475	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000186	0.00468	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000184	0.00462	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CALCRL—migraine	0.000183	0.0046	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—RAMP1—migraine	0.000183	0.0046	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—HTR1B—migraine	0.000179	0.0045	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000174	0.00437	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—HTR1A—migraine	0.000172	0.00433	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—RAMP1—migraine	0.00017	0.00428	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CALCRL—migraine	0.00017	0.00428	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—NPS—migraine	0.00017	0.00426	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—TAC1—migraine	0.00017	0.00426	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000168	0.00422	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000168	0.00421	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—HTR1D—migraine	0.000167	0.00419	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—HTR2C—migraine	0.000166	0.00418	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000166	0.00416	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000165	0.00415	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000165	0.00415	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000162	0.00407	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—EDNRA—migraine	0.000162	0.00407	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000158	0.00396	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—HTR1B—migraine	0.000157	0.00394	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000157	0.00393	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CALCA—migraine	0.000156	0.00391	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—HTR2B—migraine	0.000155	0.0039	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—RAMP1—migraine	0.000155	0.00388	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CALCRL—migraine	0.000155	0.00388	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HTR1D—migraine	0.000152	0.00381	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—HTR1A—migraine	0.000151	0.00379	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—NPS—migraine	0.000149	0.00374	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—TAC1—migraine	0.000149	0.00374	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—HTR1D—migraine	0.000146	0.00368	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—HTR2C—migraine	0.000146	0.00366	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—HTR7—migraine	0.000146	0.00366	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—EDNRA—migraine	0.000142	0.00356	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000142	0.00356	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HTR2B—migraine	0.000141	0.00354	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000137	0.00345	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CALCA—migraine	0.000137	0.00343	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—HTR2B—migraine	0.000136	0.00342	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000134	0.00337	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HTR1D—migraine	0.000133	0.00334	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—HTR1B—migraine	0.000133	0.00333	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—HTR7—migraine	0.000128	0.00321	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—HTR1A—migraine	0.000128	0.00321	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—NPS—migraine	0.000126	0.00316	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—TAC1—migraine	0.000126	0.00316	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—HTR1D—migraine	0.000124	0.00311	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HTR2B—migraine	0.000124	0.0031	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—HTR2C—migraine	0.000123	0.0031	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RAMP1—migraine	0.000123	0.0031	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CALCRL—migraine	0.000123	0.0031	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—EDNRA—migraine	0.00012	0.00301	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000118	0.00295	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000116	0.00291	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CALCA—migraine	0.000116	0.0029	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—HTR2B—migraine	0.000115	0.00289	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HTR1D—migraine	0.000112	0.00282	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RAMP1—migraine	0.000108	0.00271	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CALCRL—migraine	0.000108	0.00271	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—HTR7—migraine	0.000108	0.00271	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HTR2B—migraine	0.000104	0.00262	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—HTR2A—migraine	0.000102	0.00256	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—HTR1B—migraine	0.000101	0.00254	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	9.94e-05	0.0025	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—HTR1A—migraine	9.74e-05	0.00245	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—TAC1—migraine	9.59e-05	0.00241	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—NPS—migraine	9.59e-05	0.00241	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—HTR2C—migraine	9.41e-05	0.00236	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HTR1B—migraine	9.19e-05	0.00231	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—EDNRA—migraine	9.15e-05	0.0023	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CALCRL—migraine	9.14e-05	0.00229	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RAMP1—migraine	9.14e-05	0.00229	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HTR1D—migraine	8.96e-05	0.00225	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—HTR2A—migraine	8.95e-05	0.00225	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—HTR1B—migraine	8.87e-05	0.00223	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HTR1A—migraine	8.85e-05	0.00222	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CALCA—migraine	8.81e-05	0.00221	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—NPS—migraine	8.71e-05	0.00219	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—TAC1—migraine	8.71e-05	0.00219	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HTR2C—migraine	8.54e-05	0.00214	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—HTR1A—migraine	8.54e-05	0.00214	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—NPS—migraine	8.41e-05	0.00211	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—TAC1—migraine	8.41e-05	0.00211	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HTR2B—migraine	8.33e-05	0.00209	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—EDNRA—migraine	8.31e-05	0.00209	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—HTR2C—migraine	8.25e-05	0.00207	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—HTR7—migraine	8.24e-05	0.00207	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HTR1B—migraine	8.06e-05	0.00202	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—EDNRA—migraine	8.02e-05	0.00201	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CALCA—migraine	8e-05	0.00201	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HTR1D—migraine	7.86e-05	0.00197	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HTR1A—migraine	7.76e-05	0.00195	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CALCA—migraine	7.72e-05	0.00194	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—NPS—migraine	7.64e-05	0.00192	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—TAC1—migraine	7.64e-05	0.00192	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—HTR2A—migraine	7.57e-05	0.0019	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—HTR1B—migraine	7.5e-05	0.00188	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HTR2C—migraine	7.49e-05	0.00188	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HTR7—migraine	7.48e-05	0.00188	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—LRP1—migraine	7.33e-05	0.00184	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HTR2B—migraine	7.3e-05	0.00183	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—EDNRA—migraine	7.29e-05	0.00183	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—HTR7—migraine	7.22e-05	0.00181	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—HTR1A—migraine	7.22e-05	0.00181	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—TAC1—migraine	7.11e-05	0.00178	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—NPS—migraine	7.11e-05	0.00178	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CALCA—migraine	7.01e-05	0.00176	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—HTR2C—migraine	6.97e-05	0.00175	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HTR1B—migraine	6.81e-05	0.00171	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—EDNRA—migraine	6.78e-05	0.0017	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HTR1D—migraine	6.64e-05	0.00167	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HTR7—migraine	6.56e-05	0.00165	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HTR1A—migraine	6.55e-05	0.00165	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CALCA—migraine	6.53e-05	0.00164	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—TAC1—migraine	6.46e-05	0.00162	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—NPS—migraine	6.46e-05	0.00162	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—LRP1—migraine	6.43e-05	0.00161	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HTR2C—migraine	6.33e-05	0.00159	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HTR2B—migraine	6.17e-05	0.00155	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—EDNRA—migraine	6.16e-05	0.00155	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—HTR7—migraine	6.11e-05	0.00153	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CALCA—migraine	5.93e-05	0.00149	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—HTR2A—migraine	5.77e-05	0.00145	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOTCH4—migraine	5.63e-05	0.00141	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HTR7—migraine	5.54e-05	0.00139	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LRP1—migraine	5.43e-05	0.00136	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HTR1B—migraine	5.43e-05	0.00136	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HTR2A—migraine	5.24e-05	0.00132	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HTR1A—migraine	5.23e-05	0.00131	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NPS—migraine	5.15e-05	0.00129	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PGR—migraine	5.15e-05	0.00129	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TAC1—migraine	5.15e-05	0.00129	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—HTR2A—migraine	5.06e-05	0.00127	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HTR2C—migraine	5.05e-05	0.00127	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOTCH4—migraine	4.93e-05	0.00124	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EDNRA—migraine	4.91e-05	0.00123	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOTCH3—migraine	4.78e-05	0.0012	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HTR1B—migraine	4.76e-05	0.0012	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CALCA—migraine	4.73e-05	0.00119	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HTR2A—migraine	4.6e-05	0.00115	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HTR1A—migraine	4.58e-05	0.00115	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NPS—migraine	4.51e-05	0.00113	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TAC1—migraine	4.51e-05	0.00113	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PGR—migraine	4.51e-05	0.00113	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HTR2C—migraine	4.42e-05	0.00111	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HTR7—migraine	4.42e-05	0.00111	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EDNRA—migraine	4.3e-05	0.00108	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—HTR2A—migraine	4.28e-05	0.00107	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOTCH3—migraine	4.19e-05	0.00105	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOTCH4—migraine	4.17e-05	0.00105	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CALCA—migraine	4.14e-05	0.00104	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HTR1B—migraine	4.02e-05	0.00101	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HTR2A—migraine	3.88e-05	0.000975	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HTR7—migraine	3.88e-05	0.000973	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HTR1A—migraine	3.87e-05	0.000972	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NPS—migraine	3.81e-05	0.000957	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PGR—migraine	3.81e-05	0.000957	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TAC1—migraine	3.81e-05	0.000957	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TGFBR2—migraine	3.81e-05	0.000956	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HTR2C—migraine	3.74e-05	0.000939	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CACNA1A—migraine	3.66e-05	0.000919	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EDNRA—migraine	3.64e-05	0.000913	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOTCH3—migraine	3.55e-05	0.00089	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CALCA—migraine	3.5e-05	0.000879	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TGFBR2—migraine	3.34e-05	0.000838	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HTR7—migraine	3.28e-05	0.000822	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HTR2A—migraine	3.1e-05	0.000777	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TGFBR2—migraine	2.82e-05	0.000708	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ESR1—migraine	2.75e-05	0.00069	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HTR2A—migraine	2.71e-05	0.000682	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ESR1—migraine	2.41e-05	0.000605	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CACNA1A—migraine	2.39e-05	0.000601	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HTR2A—migraine	2.29e-05	0.000576	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ESR1—migraine	2.04e-05	0.000511	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MTHFR—migraine	1.21e-05	0.000304	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTHFR—migraine	7.92e-06	0.000199	CbGpPWpGaD
